Skip to main navigation Skip to search Skip to main content

Abstract

Objectives: The prevalence of stoma formation in the United Kingdom has risen markedly over the past decade, yet comparatively little is known about national prescribing patterns for ostomy products. A retrospective cross-sectional observational study was conducted in which the UK Prescription Cost Analysis (PCA) data for 2023 were examined to assess what information can be extracted from these datasets, to evaluate inter-nation variation in prescribing, and identify areas warranting further health economics and policy investigation.

Methods: PCA data for calendar year 2023 were collated from the four devolved
UK health services. Data on product type, manufacturer, quantities dispensed, and cost were compared across nations and product categories.

Results: Total UK prescription spend on ostomy products in 2023 was £457 million, 3.4% of overall NHS prescription expenditure. Pouches accounted for 72% (£329 million) of spend, with the remainder supporting peristomal skin health and appliance adhesion. Estimated average per-patient spend was modelled and varied substantially by nation, from £1073 in Wales to £2354 in England, against a UK average of £2243. Persistent prescribing of ancillary items no longer
recommended for routine use (filters, deodorants, bag covers) accounted for an estimated £ 8 million (>2% of spend).

Conclusions: PCA data represent an underutilized resource for population-level analysis of ostomy care. Marked inter-nation variation in expenditure, uncertainty surrounding ostomate population estimates, and the continued prescribing of ancillary items not recommended for routine use identify important evidence gaps and generate hypotheses for future research with direct relevance to prescribing policy, resource allocation, and equitable access to care across the United Kingdom.
Original languageEnglish
Article number3019
Number of pages15
JournalHealthcare
Volume14
Issue number18
Early online date14 Sept 2026
DOIs
Publication statusPublished (in print/issue) - 14 Sept 2026

Bibliographical note

Publisher Copyright:
© 2026 by the authors.

Rights Retention Statement

This Author Accepted Manuscript has been made open access under a Creative Commons Attribution 4.0 International licence (CC BY 4.0) under the terms of Ulster University Rights Retention Policy for Scholarly Works. To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/.

Data Availability Statement

The data used in the compilation of the tables and figures are freely available from the Prescription Cost Analysis pages within the National Health Service Business Services Authorities for each of the devolved nations.

Funding

This work was supported by the UK Medical Research Council (UKRI804) relating to the development of leak detection and diagnostic sensing technologies for use with stoma pouches.

FundersFunder number
Medical Research CouncilUKRI804

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Keywords

    • stoma
    • ostomy
    • prescribing
    • prescription cost analysis
    • health policy
    • National Health Service

    Fingerprint

    Dive into the research topics of 'National Prescribing Patterns in Stoma Care Across the United Kingdom: A Prescription Cost Analysis with Health Policy Implications'. Together they form a unique fingerprint.

    Cite this